How to structure a loyalty program in a pharmacy?
A pharmacy loyalty program should start with a clear objective, a legally validated list of eligible products and services, simple rules and specific controls for data that may reveal health information. The pharmacy also needs to calculate the cost of rewards, train staff, communicate the terms, and measure usage, margin and operational issues.
The program does not guarantee customer retention, increased visit frequency or sales growth. In the pharmaceutical sector, the relationship with the customer involves trust, professional guidance and rules that cannot be replaced by commercial incentives. Patient safety and the rational use of medicines must remain above marketing goals.
What is a pharmacy loyalty program?
It is a framework that identifies participants and grants benefits according to eligible actions. The model can use points, coupons, services, perks or rewards, provided it respects the limitations applicable to pharmaceutical products and promotional initiatives.
The program should separate three activities:
- loyalty operation: registration, balance, rules and redemption;
- commercial communication: messages, campaigns and offers;
- profiling: analysis of preferences or behaviors for personalization.
Enrollment in the program should not be used automatically as authorization for all these purposes. Each processing requires clear information, an appropriate basis and proportional controls.
1. Define the objective without interfering with pharmaceutical care
The objective should be related to a real operational need and not to indiscriminate stimulation of consumption. Examples that can be considered include facilitating access to benefits, recognizing the use of eligible services, organizing perks in permitted categories or replacing manual controls with auditable records.
Avoid goals that encourage unnecessary purchase of medicines or that pressure staff to turn health guidance into sales. Also do not link rewards to claims of prevention, treatment or clinical outcome.
2. Determine which products and services can participate
Before choosing points or discounts, the pharmacy must create an eligibility matrix reviewed by legal, regulatory, tax and pharmaceutical responsibles. Classification cannot rely solely on the product’s commercial registration.
| Category to evaluate | Mandatory question | Main risk | Decision to document |
|---|---|---|---|
| Prescription medicines | Is inclusion, promotion or communication allowed? | Incentive or advertising incompatible with applicable rules. | Exclude or apply the treatment determined by the local review. |
| Over-the-counter medicines | What authorizations and advertising limits apply? | Unauthorized, misleading or use-promoting messaging. | Define eligibility and communication only after regulatory validation. |
| Non-medicinal products | Are there category-specific restrictions or health claims? | Treat every pharmacy product as a standard promotional commodity. | Classify by category, margin and applicable rule. |
| Pharmacy services | Does the benefit affect professional independence or care? | Confusing commercial promotion with clinical recommendation. | Separate service information, eligibility and any perk. |
| Prizes and sweepstakes | Is the initiative an operation or contest subject to formalities? | Failure to comply with registration, rules, guarantees or legal exclusions. | Submit the design to legal review before disclosure. |
The list should be reviewed when products, legislation, campaigns or suppliers change. The system must apply eligibility at the time of transaction and record the version of the rule used.
3. Choose a reward compatible with margin and ethics
The reward can be a coupon, a service benefit, a partner perk or an approved item, among other possibilities validated. The value must be understandable and should not encourage excessive consumption or replace professional advice.
To estimate sustainability:
Total program cost = rewards redeemed + technology + communication + training + customer service + reconciliation + losses
Cost per active participant = total program cost ÷ participants who performed at least one valid action in the period
The analysis should consider contribution margin of eligible categories. Revenue is not margin, and unredeemed rewards should not be the only reason the model appears viable.
4. Write clear and verifiable rules
The regulation should inform:
- who can participate and how to enroll;
- which products, services and locations are eligible;
- how benefits are calculated;
- when the balance becomes available;
- limits, validity and redemption conditions;
- treatment of returns, cancellations and corrections;
- how to check balance and dispute a transaction;
- how changes and termination will be communicated;
- which data purposes are involved.
Essential conditions must appear alongside the offer, not only in a hard-to-find document. The current version of the regulation should be recorded.
5. Protect data and separate consents
Purchase history in a pharmacy can reveal or allow inferences about health status. Therefore, the company should not treat all loyalty data as simple commercial information. The GDPR considers health data a category that requires enhanced protection.
The program should apply minimization: record only what is necessary to execute the rule. When calculation can be done by eligible category and value, do not store product details just because they are available.
Enrollment, marketing and profiling should be presented separately. The customer needs to understand which choices are necessary to participate and which are optional. A refusal of promotional communication should not prevent access to the balance and redemption when those channels are not necessary for the contract.
The mapping should identify:
- controller, processors and other recipients;
- purpose and legal basis of each processing;
- data collected, including inferences;
- retention periods;
- permissions and access logs;
- transfers and suppliers involved;
- data subject rights and support channels;
- incident response and data deletion.
6. Avoid personalization based on health conditions
A purchase does not authorize assuming a diagnosis, treatment or future need. Campaigns based on medicines purchased or health services may produce sensitive profiling and undue exposure.
For general communications, prefer less invasive signals, such as interest categories declared by the customer, chosen channel and operational status of the benefit. Even this information requires purpose, transparency and control.
Do not send messages that reveal a possible health condition on the lock screen, in an email subject line or to a shared number. Content and channel should be evaluated together.
7. Organize the flow at the counter and in digital channels
- The customer receives information about the program without pressure.
- Enrollment records only necessary data.
- Optional preferences are requested separately.
- The sale identifies eligible items according to the current rule.
- The benefit is calculated without interfering with pharmaceutical guidance.
- Pending or available balance is communicated discreetly.
- Redemption validates eligibility, limit and expiry.
- Cancellations and returns generate the corresponding correction.
Staff must be able to explain the program, but must not infer consent or comment on prior purchases in front of third parties. Screens and receipts should avoid unnecessary exposure of information.
8. Train staff and control permissions
Training should cover commercial rules, privacy and customer service. Each role should access only what is necessary. Manual balance adjustments require specific permission, a reason and an audit log.
Include simulations of enrollment, marketing refusal, redemption, return, duplicate account, customer without access to the registered contact and privacy requests. Errors must be reported and corrected, not bypassed with generic accounts or external notes.
9. Communicate without making medical claims
Program communications should address rules, balance, validity and authorized benefits. Do not link the reward to promises of preventing, diagnosing, treating or curing health conditions. Public advertising of medicines has its own restrictions in Italy and, in certain cases, requires prior authorization.
Before sending a campaign, confirm:
- whether the product and message can be promoted to the public;
- whether necessary authorizations have been obtained;
- whether the audience and channel are appropriate;
- whether the offer conditions are visible;
- whether the list respects communication choices;
- whether the text avoids exaggeration, fear or encouragement of irrational use.
Hypothetical pilot example
Simulation, not recommendation: an Italian pharmacy considers a 90-day pilot limited to non-medicinal products whose eligibility has been locally reviewed. For each defined value in valid purchases, the customer accumulates points that can be exchanged for a benefit from an approved list.
Medicines and non-validated categories are excluded. The transactional record sent to the program uses eligible category, value, date and sale identifier, without retaining the detailed product names in the marketing system. Enrollment, commercial messages and profiling have separate choices.
Before launch, the pharmacy calculates the maximum cost, trains staff and tests cancellation and redemption. During the pilot, it monitors usage, margin, errors, complaints and privacy requests. The 90 days and the rule described are only examples; they do not constitute a legal or commercial standard.
Which metrics to track?
| Metric | Suggested calculation | Decision supported | Interpretation caveat |
|---|---|---|---|
| Enrollment | New participants ÷ eligible customers informed | Assess clarity and execution of enrollment. | Enrollment does not equal loyalty. |
| Activation | Participants with first valid transaction ÷ new participants | Check if the program starts being used. | Define an equivalent time window. |
| Redemption rate | Benefits used ÷ benefits released | Assess use and accessibility of rewards. | Compare benefits with similar maturity. |
| Cost per use | Total program cost ÷ benefits used | Review sustainability. | Include technology, staff and compliance. |
| Margin after benefits | Eligible net revenue − variable costs − rewards − attributable costs | Review the rule by category. | Do not analyze revenue only. |
| Errors and adjustments | Corrected transactions ÷ program transactions | Improve system and training. | Separate technical, human and fraud causes. |
| Privacy complaints | Occurrences by type and period | Review transparency, access and communications. | Even a serious incident requires immediate action. |
Comparisons between participants and non-participants may suffer selection bias: already frequent customers tend to enroll more. Do not attribute causality to the program without proper measurement design.
Checklist before launch
- Define an objective that does not interfere with pharmaceutical care.
- Validate eligible products, services, rewards and messages.
- Review Italian rules on medicines and prize operations.
- Calculate total cost and margin by category.
- Document accrual, redemption, validity, returns and termination.
- Separate enrollment, marketing and profiling.
- Minimize data and avoid unnecessary health details.
- Map suppliers, accesses, retention and incidents.
- Test sale, deletion, redemption, cancellation and correction.
- Train pharmacists, attendants, managers and support.
- Run a pilot with financial and scope limits.
- Measure usage, cost, margin, errors and complaints.
- Obtain legal, regulatory and privacy review in Italy.
Next step
A responsible pharmacy program combines simple rules, validated categories, enhanced data protection and an operation that respects the pharmacy’s professional role. Technology should execute this design without turning health information into inappropriate advertising.
After local review and requirement definition, discover the loyalty program solution from Smartbis. Confirm in a demo which features, plans, integrations, controls and data options meet the operation and applicable requirements in Italy.